Markets Jefferies starts SI-BONE at buy; PT $20 Jefferies launched coverage of SI-BONE (NASDAQ:SIBN) with a “buy” rating and $20 price target. The stock closed at $15.71 on Oct. 11. SI-BONE is the current market and innovation leader in sacropelvic spine surgery... October 12, 2022